Cell-Free DNA as Alternative to Bone Marrow CD19+Selection for Diagnostic MYD88 L265P in Waldenstrom's Macroglobulinemia

被引：0

作者：

Demos, Maria ^{[1
]}

Xu, Lian ^{[1
]}

Tsakmaklis, Nickolas ^{[1
]}

Kofides, Amanda ^{[1
]}

Chen, Jiaji ^{[1
]}

Munshi, Manit ^{[1
]}

Liu, Xia ^{[1
]}

Jimenez, Cristina ^{[1
]}

Chan, Gloria ^{[1
]}

Guerrera, Maria Luisa ^{[1
]}

Meid, Kirsten ^{[1
]}

Keezer, Andrew ^{[1
]}

Yang, Guang ^{[1
]}

Hunter, Zachary ^{[1
]}

Castillo, Jorge ^{[1
]}

Treon, Steven ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

cell-free DNA; MYD88; Waldenstrom macroglobulinemia;

D O I：

10.1016/j.clml.2019.09.511

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SP-185

引用

页码：E311 / E311

页数：1

共 10 条

[1] MYD88 L265P mutation in cutaneous involvement by Waldenstrom macroglobulinemia
Alegria-Landa, Victoria
Prieto-Torres, Lucia
Santonja, Carlos
Cordoba, Raul
Manso, Rebeca
Requena, Luis
Rodriguez-Pinilla, Socorro M.
JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (07) : 625 - 631
[2] An unusual case of cutaneous Waldenstrom macroglobulinemia with the MYD88 L265P mutation
Minzenmayer, Andrew N.
Miranda, Roberto N.
Powell, Priscilla R.
Parekh, Palak K.
JOURNAL OF CUTANEOUS PATHOLOGY, 2020, 47 (09) : 850 - 853
[3] Detection of the MYD88L265P and CXCR4S338X mutations by cell-free DNA in Waldenstrom macroglobulinemia
Wu, Yan-Yan
Jia, Ming-Nan
Cai, Hao
Qiu, Yu
Zhou, Dao-Bin
Li, Jian
Cao, Xin-Xin
ANNALS OF HEMATOLOGY, 2020, 99 (08) : 1763 - 1769
[4] MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma
Hiemcke-Jiwa, Laura S.
Leguit, Roos J.
Snijders, Tom J.
Bromberg, Jacoline E. C.
Nierkens, Stefan
Jiwa, N. Mehdi
Minnema, Monique C.
Huibers, Manon M. H.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 974 - 977
[5] MYD88 L265P Somatic Mutation Its Usefulness in the Differential Diagnosis of Bone Marrow Involvement by B-Cell Lymphoproliferative Disorders
Ondrejka, Sarah L.
Lin, Jeffrey J.
Warden, Doug W.
Durkin, Lisa
Cook, James R.
Hsi, Eric D.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (03) : 387 - 394
[6] MYD88 L265P mutation analysis is a useful diagnostic adjunct for lymphoplasmacytic lymphoma with pleural effusion
Pan, Shien-Tung
Wang, Ren Ching
Kuo, Chun-Chi
Hsieh, Yen-Chuan
Su, Ying-Zhen
Chuang, Shih-Sung
PATHOLOGY INTERNATIONAL, 2019, 69 (10) : 601 - 607
[7] Detection of the MYD88L265P and CXCR4S338X mutations by cell-free DNA in Waldenström macroglobulinemia
Yan-Yan Wu
Ming-Nan Jia
Hao Cai
Yu Qiu
Dao-Bin Zhou
Jian Li
Xin-Xin Cao
Annals of Hematology, 2020, 99 : 1763 - 1769
[8] Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia
Insuasti-Beltran, Giovanni
Gale, James M.
Wilson, Carla S.
Foucar, Kathryn
Czuchlewski, David R.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (08) : 1035 - 1041
[9] Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma
Ansell, S. M.
Hodge, L. S.
Secreto, F. J.
Manske, M.
Braggio, E.
Price-Troska, T.
Ziesmer, S.
Li, Y.
Johnson, S. H.
Hart, S. N.
Kocher, J-P A.
Vasmatzis, G.
Chanan-Kahn, A.
Gertz, M.
Fonseca, R.
Dogan, A.
Cerhan, J. R.
Novak, A. J.
BLOOD CANCER JOURNAL, 2014, 4 : e183 - e183
[10] Defining Lymphoplasmacytic Lymphoma Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
Fang, Hong
Kapoor, Prashant
Gonsalves, Wilson I.
Frederick, Lori A.
Viswanatha, David
Howard, Matthew T.
He, Rong
Morice, William G., II
McPhail, Ellen D.
Greipp, Patricia T.
Ansell, Stephen M.
Kyle, Robert A.
Gertz, Morie A.
Paludo, Jonas
Abeykoon, Jithma
King, Rebecca L.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 (02) : 168 - 176

← 1 →